Sign in
4

Changes in Ownership

Denali Therapeutics Inc. Filed Acc 0001714899-23-000055

COFO and Secretary sold 10,000 shares at $25.04 ($250,400)

  • COFO and Secretary acquired 10,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Schuth Alexander O. · COFO and Secretary

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2023-04-12 Exercise or conversion : show line 1 in the form +5,102 $5.28 $26,939 533,793 I
2023-04-12 Sale : show line 2 in the form −5,102 $25.04 $127,754 528,691 I
2023-04-13 Exercise or conversion : show line 3 in the form +4,898 $5.28 $25,861 533,589 I
2023-04-13 Sale : show line 4 in the form −4,898 $25.04 $122,646 528,691 I
Open-market sales · 10,000 sh · avg $25.04 · $250,400

Table II: Derivative

2 lines
Date Transaction Shares Owned after D/I
2023-04-12 Exercise or conversion : show line 5 in the form Stock Option (right to buy) −5,102 93,835 D
2023-04-13 Exercise or conversion : show line 6 in the form Stock Option (right to buy) −4,898 88,937 D
Loading xslF345X04/wf-form4_168151121787982.xml…